Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy

Progress in Nuclear Magnetic Resonance Spectroscopy

Volumn 49, Issue 1, 2006, Pages 65-98

  Berners Price, Susan J ^a   Ronconi, Luca ^b   Sadler, Peter J ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

15N NMR; 195Pt NMR; 1H,15N NMR; Aquation; DNA; Glutathione; Kinetics; NMR; Platinum drugs; Proteins

Indexed keywords

DISEASE CONTROL; DNA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLATINUM; PROTEINS; REACTION KINETICS; TUMORS;

15N NMR; 195PT NMR; AQUATION; KINETICS; PLATINUM DRUGS;

DRUG PRODUCTS;

EID: 33748102436     PISSN: 00796565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnmrs.2006.05.002     Document Type: Review

References (182)

1. Muggia F.M. Semin. Oncol. 31 Suppl. 14 (2004) 17
2. Haller D.G. Semin. Oncol. 31 Suppl. 14 (2004) 10
3. Belani C.P. Semin. Oncol. 31 Suppl. 14 (2004) 25
4. Lippert B. Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich
5. Kelland L.R., and Farrell N.P. Platinum-Based Drugs in Cancer Therapy (2000), Humana Press, New Haven
6. Farrell N. Semin. Oncol. 31 Suppl. 14 (2004) 1
7. Hambley T.W. J. Chem. Soc. Dalton Trans. (2001) 2711
8. Jamieson E.R., and Lippard S.J. Chem. Rev. 99 (1999) 2467
9. Reedijk J. Chem. Rev. 99 (1999) 2499
10. Wang D., and Lippard S.J. Nat. Rev. Drug Discov. 4 (2005) 307
11. Macdonald F., and Sadler P.J. Platinum-195 NMR Spectroscopy: Applications to the Study of Anticancer Drugs. In: McBrien D.C.H., and Slater T.F. (Eds). Biochemical Mechanisms of Platinum Antitumour Drugs (1986), IRL Press, Oxford 361-381
12. Ismail I.M., and Sadler P.J. ACS Symp. Ser. 209 (1983) 171
13. Berners-Price S.J., Frenkiel T.A., Frey U., Ranford J.D., and Sadler P.J. J. Chem. Soc. Chem. Commun. (1992) 789
14. Barnham K.J., Berners-Price S.J., Guo Z., Murdoch P.d.S., and Sadler P.J. NMR spectroscopy of platinum drugs: from DNA to body fluids. In: Pinendo H.M., and Schornagel J.H. (Eds). Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 (1996), Plenum Press, New York 1-16
15. Berners-Price S.J., and Sadler P.J. Coord Chem Rev 151 (1996) 1
16. 15N-NMR spectroscopic studies of cisplatin reactions with biomolecules. In: Lippert B. (Ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 293-318
17. Li F., and Sun H. Dynamic and kinetic aspects of metallodrugs by NMR. In: Gielen M., Willem R., and Wrackmeier B. (Eds). Physical Organometallic Chemistry 4 (2004), John Wiley & Sons, New York 163-217
18. Ano S.O., Kuklenyik Z., and Marzilli L.G. Structure and dynamics of Pt anticancer drug adducts from nucleotides to oligonucleotides as revealed by NMR methods. In: Lippert B. (Ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 247-291
19. Marzilli L.G., Saad J.S., Kuklenyik Z., Keating K.A., and Xu Y. J. Am. Chem. Soc. 123 (2001) 2764
20. Sullivan S.T., Ciccarese A., Fanizzi F.P., and Marzilli L.G. J. Am. Chem. Soc. 123 (2001) 9345
21. Sullivan S.T., Ciccarese A., Fanizzi F.P., and Marzilli L.G. Inorg. Chem. 40 (2001) 455
22. Sullivan S.T., Saad J.S., Fanizzi F.P., and Marzilli L.G. J. Am. Chem. Soc. 124 (2002) 1558
23. Becker M., Port R.E., Zabel H.-J., Zeller W.J., and Bachert P. J. Magn. Reson. 133 (1998) 115
24. Pregosin P.S. Coord. Chem. Rev. 44 (1982) 247
25. Ismail I.M., Kerrison S.J.S., and Sadler P.J. Polyhedron 1 (1982) 57
26. Robillard M.S., Leith J.S., van der Marel G.A., van Boom J.H., and Reedijk J. Eur. J. Inorg. Chem. (2003) 1529
27. Rosenberg B. Biochimie 60 (1978) 859
28. Bancroft D.P., Lepre C.A., and Lippard S.J. J. Am. Chem. Soc. 112 (1990) 6860
29. Stefanov V.E., Tulub A.A., and Kutin A.A. Int. J. Biol. Macromol. 26 (1999) 161
30. Tulub A.A., and Stefanov V.E. Int. J. Biol. Macromol. 28 (2001) 191
31. Norman R.E., and Sadler P.J. Inorg. Chem. 27 (1988) 3583
32. Pregosin P.S., Omura H., and Venanzi L.M. J. Am. Chem. Soc. 95 (1973) 2047
33. Appleton T.G., Hall J.R., and Ralph S.F. Inorg. Chem. 24 (1985) 4685
34. Berners-Price S.J., and Kuchel P.W. J. Inorg. Biochem. 38 (1990) 305
35. Berners-Price S.J., and Kuchel P.W. J. Inorg. Biochem. 38 (1990) 327
36. L. Ronconi, F.S. Mackay, P.J. Sadler, unpublished results.
37. Chen H., Parkinson J.A., Morris R.E., and Sadler P.J. J. Am. Chem. Soc. 125 (2003) 173
38. Chen H., Parkinson J.A., Parsons S., Coxall R.A., Gould R.O., and Sadler P.J. J. Am. Chem. Soc. 124 (2002) 3064
39. Wang F., Bella J., Parkinson J.A., and Sadler P.J. J. Biol. Inorg. Chem. 10 (2005) 147
40. Chen H., Parkinson J.A., Novakova O., Bella J., Wang F., Dawson A., Gould R., Parsons S., Brabec V., and Sadler P.J. Proc. Natl. Acad. Sci. USA 100 (2003) 14623
41. Stonehouse J., Shaw G.L., Keeler J., and Laue E.D. J. Magn. Res. Ser. A 107 (1994) 174
42. Anderson B., and Sletten E. J. Inorg. Biochem. 79 (2000) 353
43. Liu Y., Vinje J., Pacifico C., Natile G., and Sletten E. J. Am. Chem. Soc. 124 (2002) 12854
44. Barbarella G., Bertoluzza A., Morelli M.A., Tosi M.R., and Tuglioni V. Gazz. Chim. Ital. 118 (1988) 637
45. Rosenberg B. Met. Ions Biol. Syst. 11 (1980) 127
46. Howe-Grant M., and Lippard S.J. Met. Ions Biol. Syst. 11 (1980) 63
47. Berners-Price S.J., and Appleton T.G. The chemistry of cisplatin in aqueous solution. In: Kelland L.R., and Farrell N.P. (Eds). Platinum-Based Drugs in Cancer Therapy (2000), Humana Press, New Haven 3-35
48. Appleton T.G., Hall J.R., Ralph S.F., and Thompson C.S.M. Inorg. Chem. 28 (1989) 1989
49. Appleton T.G., Bailey A.J., Barnham K.J., and Hall J.R. Inorg. Chem. 31 (1992) 3077
50. Guo Z., Chen Y., Zang E., and Sadler P.J. J. Chem. Soc. Dalton Trans. (1997) 4107
51. Barton S.J., Barnham K.J., Habtemariam A., Sue R.E., and Sadler P.J. Inorg. Chim. Acta 273 (1998) 8
52. Chen Y., Guo Z., Parsons S., and Sadler P.J. Chem. Eur. J. 4 (1998) 672
53. Hotze A.C.G., Chen Y., Hambley T.W., Parsons S., Kratochwil N.A., Parkinson J.A., Munk V.P., and Sadler P.J. Eur. J. Inorg. Chem. (2002) 1035
54. McGowan G., Parsons S., and Sadler P.J. Inorg. Chem. 44 (2005) 7459
55. Davies M.S., Cox J.W., Berners-Price S.J., Barklage W., Qu Y., and Farrell N. Inorg. Chem. 39 (2000) 1710
56. Davies M.S., Thomas D.S., Hegmans A., Berners-Price S.J., and Farrell N. Inorg. Chem. 41 (2002) 1101
57. Zhang J., Thomas D.S., Davies M.S., Berners-Price S.J., and Farrell N. J. Biol. Inorg. Chem. 10 (2005) 652
58. Davies M.S., Berners-Price S.J., and Hambley T.W. Inorg. Chem. 39 (2000) 5603
59. Centerwall C.R., Goodisman J., Kerwood D.J., and Dabrowiak J.C. J. Am. Chem. Soc. 127 (2005) 12768
60. Tacka K.A., Szalda D., Souid A.-K., Goodisman J., and Dabrowiak J.C. Chem. Res. Toxicol. 17 (2004) 1434
61. Berners-Price S.J., Frenkiel T.A., Ranford J.D., and Sadler P.J. J. Chem. Soc. Dalton Trans. (1992) 2137
62. Berners-Price S.J., Frey U., Ranford J.D., and Sadler P.J. J. Am. Chem. Soc. 115 (1993) 8649
63. Berners-Price S.J., Ranford J.D., and Sadler P.J. Inorg. Chem. 33 (1994) 5842
64. Guo Z., Sadler P.J., and Zang E. Chem. Commun. (1997) 27
65. Murdoch P.d.S., Guo Z., Parkinson J.A., and Sadler P.J. J. Biol. Inorg. Chem. 4 (1999) 32
66. Barnham K.J., Berners-Price S.J., Frenkiel T.A., and Sadler P.J. Angew. Chem. Int. Ed. 34 (1995) 1874
67. Berners-Price S.J., Barnham K.J., Frey U., and Sadler P.J. Chem. Eur. J. 2 (1996) 1283
68. Reeder F., Guo Z., Murdoch P.d.S., Corazza A., Hambley T.W., Berners-Price S.J., Chottard J.-C., and Sadler P.J. Eur. J. Biochem. 249 (1997) 370
69. Berners-Price S.J., Corazza A., Guo Z., Barnham K.J., Sadler P.J., Ohyama Y., Leng M., and Locker D. Eur. J. Biochem. 243 (1997) 782
70. Pil P.M., and Lippard S.J. Science 256 (1992) 234
71. McA'Nulty M.M., and Lippard S.J. Nucleic Acids Mol. Biol. 9 (1995) 264
72. Fichtinger-Schepman A.-M.J., van der Veer J.L., den Hartog J.H.J., Lohman P.H.M., and Reedijk J. Biochemistry 24 (1985) 707
73. Eastman A. The mechanism of action of cisplatin: from adducts to apoptosis. In: Lippert B. (Ed). Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 111-134
74. Davies M.S., Berners-Price S.J., and Hambley T.W. J. Am. Chem. Soc. 120 (1998) 11380
75. Davies M.S., Berners-Price S.J., and Hambley T.W. J. Inorg. Biochem. 79 (2000) 167
76. Davies M.S., Berners-Price S.J., Jones A.R., and Hambley T.W. J. Inorg. Biochem. 96 (2003) 121
77. M.S. Davies, A.R. Jones, S.J. Berners-Price, T.W. Hambley, unpublished results.
78. Vinje J., Sletten E., and Kozelka J. Chem. Eur. J. 11 (2005) 3863
79. Vinje J., Parkinson J.A., Sadler P.J., Brown T., and Sletten E. Chem. Eur. J. 9 (2003) 1620
80. Vinje J., and Sletten E. Chem. Eur. J. 12 (2006) 676
81. Chen Y., Parkinson J.A., Guo Z., Brown T., and Sadler P.J. Angew. Chem. Int. Ed. 38 (1999) 2060
82. Vinje J., Intini F.P., Natile G., and Sletten E. Chem. Eur. J. 10 (2004) 3569
83. Riley C.M., Sternson L.A., Repta A.J., and Slyter S.A. Anal. Biochem. 130 (1983) 203
84. Norman R.E., Ranford J.D., and Sadler P.J. Inorg. Chem. 31 (1992) 877
85. Murdoch P.d.S., Ranford J.D., Sadler P.J., and Berners-Price S.J. Inorg. Chem. 32 (1993) 2249
86. Appleton T.G., Connor J.W., and Hall J.R. Inorg. Chem. 27 (1988) 130
87. Chen Y., Guo Z., Murdoch P.d.S., Zang E., and Sadler P.J. J. Chem. Soc., Dalton Trans. (1998) 1503
88. El-Khateeb M., Appleton T.G., Gahan L.R., Charles B.G., Berners-Price S.J., and Bolton A.-M. J. Inorg. Biochem. 77 (1999) 13
89. Fröhling C.D.W., and Sheldrick W.S. Chem. Commun. (1997) 1737
90. Appleton T.G., Hall J.R., and Ralph S.F. Aus. J. Chem. 39 (1986) 1347
91. Appleton T.G., Connor J.W., Hall J.R., and Prenzler P.D. Inorg. Chem. 28 (1989) 2030
92. Gibson D., Kasherman Y., Kowarski D., and Freikman I. J. Biol. Inorg. Chem. 11 (2006) 179
93. Reedijk J., and Teuben J.M. Platinum-sulfur interactions involved in antitumor drugs, rescue agents, and biomolecules. In: Lippert B. (Ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 339-362
94. Ishikawa T., Bao J.-J., Yamane Y., Akimaru K., Frindrich K., Wright C.D., and Kuo M.T. J. Biol. Chem. 271 (1996) 14981
95. Dorr R.T. A review of the modulation of cisplatin toxicities by chemoprotectants. In: Pinedo H.M., and Schornagel J.H. (Eds). Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 (1996), Plenum Press, New York 131-154
96. Murdoch P.d.S., Kratochwil N.A., Parkinson J.A., Patriarca M., and Sadler P.J. Angew. Chem. Int. Ed. 38 (1999) 2949
97. Fakih S., Munk V.P., Shipman M.A., Murdoch P.d.S., Parkinson J.A., and Sadler P.J. Eur. J. Inorg. Chem. (2003) 1206
98. Barnham K.J., Djuran M.I., Murdoch P.d.S., and Sadler P.J. J. Chem. Soc., Chem. Commun. (1994) 721
99. Djuran M.I., Lempers E.L.M., and Reedijk J. Inorg. Chem. 30 (1991) 2648
100. van Boom S.S.G.E., and Reedijk J. J. Chem. Soc. Chem. Commun. (1993) 1397
101. Barnham K.J., Djuran M.I., Murdoch P.d.S., Ranford J.D., and Sadler P.J. J. Chem. Soc. Dalton Trans. (1995) 3721
102. Lempers E.L.M., and Reedijk J. Inorg. Chem. 29 (1990) 217
103. Rao M., and Rao M.A. J. Pharm. Pharmacol. 50 (1998) 687
104. Liu Q., Zhang J., Ke X., Mei Y., Zhu L., and Guo Z. J. Chem. Soc. Dalton Trans. (2001) 911
105. Liu Q., Lin J., Jiang P., Zhang J., Zhu L., and Guo Z. Eur. J. Inorg. Chem. (2002) 2170
106. Kratz F. Interactions of antitumor metal complexes with serum proteins. Perspectives for anticancer drug development. In: Keppler B.K. (Ed). Metal Complexes in Cancer Chemotherapy (1993), VCH, Weinheim 391-429
107. Esposito B.P., and Najjar R. Coord. Chem. Rev. 232 (2002) 137
108. Desimone P.A., Brennan L., Cattaneo M.L., and Zukka E. Proc. Am. Soc. Clin. Oncol. 6 (1987) 33
109. Hoshino T., Misaki M., Yamamoto M., Shimizu H., Ogawa Y., and Toguchi H. J. Pharm. Sci. 84 (1995) 216
110. Nanji A.A., Stewart D.J., and Mikhael N.Z. Cancer Chemother. Pharmacol. 17 (1986) 274
111. Ivanov A.I., Christodoulou J., Parkinson J.A., Barnham K.J., Tucker A., Woodrow J., and Sadler P.J. J. Biol. Chem. 273 (1998) 14721
112. Pizzo S.V., Swaim M.W., Roeche P.A., and Gonias S.L. J. Inorg. Biochem. 33 (1988) 67
113. Cox M.C., Barnham K.J., Frenkiel T.A., Hoeschele J.D., Mason A.B., He Q.-Y., Woodworth R.C., and Sadler P.J. J. Biol. Inorg. Chem. 4 (1999) 621
114. Beatty E.J., Cox M.C., Frenkiel T.A., Tam B.M., Mason A.B., Macgillivray R.T.A., Sadler P.J., and Woodworth R.C. Biochemistry 35 (1996) 7635
115. Vijay-Kumar S., Bugg C.E., and Cook W.J. J. Mol. Biol 194 (1987) 525
116. Weber P.L., Brown S.C., and Mueller L. Biochemistry 26 (1987) 7282
117. Peleg-Shulman T., and Gibson D. J. Am. Chem. Soc. 123 (2001) 3171
118. Peleg-Shulman T., Najajreh Y., and Gibson D. J. Inorg. Biochem. 91 (2002) 306
119. Najajreh Y., Peleg-Shulman T., Moshel O., Farrell N., and Gibson D. J. Biol. Inorg. Chem. 8 (2003) 167
120. Frey U., Ranford J.D., and Sadler P.J. Inorg. Chem. 32 (1993) 1333
121. Barnham K.J., Djuran M.I., Murdoch P.d.S., Ranford J.D., and Sadler P.J. Inorg. Chem. 35 (1996) 1065
122. Barnham K.J., Frey U., Murdoch P.d.S., Ranford J.D., and Sadler P.J. J. Am. Chem. Soc. 116 (1994) 11175
123. Reedijk J. Chem. Commun. (1996) 801
124. Raynaud F.I., Boxall F.E., Goddard P.M., Valenti M., Jones M., Murrer B.A., Abrams M., and Kelland L.R. Clin. Cancer. Res. 3 (1997) 2063
125. Holford J., Sharp S.Y., Murrer B.A., Abrams M., and Kelland L.R. Br. J. Cancer 77 (1998) 366
126. F. Raynaud, F. Boxall, P. Goddard, M. Valenti, M. Jones, B. Murrer, C. Giandomenico, L. Kelland, in: Proc 88th Annual Meeting American Assoc. Cancer Res., San Diego, CA, USA, April 12-16, 1997, vol 38, No. 2085, p. 2311.
127. Chen Y., Guo Z., Parkinson J.A., and Sadler P.J. J. Chem. Soc., Dalton Trans. (1998) 3577
128. Rosenberg B. Platinum complexes for the treatment of cancer: why the search goes on. In: Lippert B. (Ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 3-27
129. Farrell N. Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry. In: Sigel A., and Sigel H. (Eds). Metal Ions in Biological Systems 32 (1996), Marcel Dekker Inc., New York 603-639
130. Natile G., and Coluccia M. Trans-platinum compounds in cancer therapy: a largely unexplored strategy for identifying novel antitumor platinum drugs. In: Clarke M.J., and Sadler P.J. (Eds). Topics in Biological Inorganic Chemistry, Metallopharmaceuticals I (1999), Springer-Verlag, Berlin 73-98
131. Kankia B.I., Funck T., and Marky L.A. J. Solut. Chem. 28 (1999) 1249
132. Pizarro A.M., Munk V.P., Navarro-Ranninger C., and Sadler P.J. Angew. Chem. Int. Ed. 42 (2003) 5339
133. Kuroda R., Neidle S., Ismail I.M., and Sadler P.J. Inorg. Chem. 22 (1983) 3620
134. Brabec V., Vrana O., Novakova O., Kleinwachter V., Intini F.P., Coluccia M., and Natile G. Nucleic Acid Res. 24 (1996) 336
135. Liu Y., Intini F.P., Natile G., and Sletten E. J. Chem. Soc. Dalton Trans. (2002) 3489
136. Hall M.D., and Hambley T.W. Coord. Chem. Rev. 232 (2002) 49
137. Poon G.K., Raynaud F.I., Mistry P., Odell D.E., Donaghue A., Kelland L.R., Harrap K.R., Barnard C.F.J., and Murrer B.A. J. Chromatogr. A. 712 (1995) 61
138. M.D. Hall, M.S. Davies, S.J. Berners-Price, T.W. Hambley, unpublished results.
139. Milgrom L., and MacRobert S. Chem. Br. 34 (1998) 45
140. Kratochwil N.A., Bednarski P.J., Mozek H., Vogler A., and Nagle J.K. Anti-Cancer Drug Des. 11 (1996) 155
141. Kratochwil N.A., Zabel M., Range K.-J., and Bednarski P.J. J. Med. Chem. 39 (1996) 2499
142. Kratochwil N.A., Parkinson J.A., Bednarski P.J., and Sadler P.J. Angew. Chem. Int. Ed. 38 (1999) 1460
143. Kratochwil N.A., Guo Z., Murdoch P.d.S., Parkinson J.A., Bednarski P.J., and Sadler P.J. J. Am. Chem. Soc. 120 (1998) 8253
144. Kratochwil N.A., Ivanov A.I., Patriarca M., Parkinson J.A., Gouldsworthy A.M., Murdoch P.d.S., and Sadler P.J. J. Am. Chem. Soc. 121 (1999) 8193
145. Müller P., Schröder B., Parkinson J.A., Kratochwil N.A., Coxall R.A., Parkin A., Parsons S., and Sadler P.J. Angew. Chem. Int. Ed. 42 (2003) 335
146. Kaspárková J., Mackay F.S., Brabec V., and Sadler P.J. J. Biol. Inorg. Chem. 8 (2003) 741
147. Mackay F.S., Woods J.A., Moseley H., Ferguson J., Dawson A., Parsons S., and Sadler P.J. Chem. Eur. J. 12 (2006) 3155
148. Farrell N., Qu Y., Bierbach U., Valsecchi M., and Menta E. Structure-activity relationships within di- and trinuclear platinum phase I clinical anticancer agents. In: Lippert B. (Ed). Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (1999), VCHA & Wiley-VCH, Zurich 479-496
149. Farrell N. Metals Biol. Syst. 41 (2004) 252
150. Farrell N.P., de Almeida S.G., and Skov K.A. J. Am. Chem. Soc. 110 (1988) 5018
151. Zaludová R., Zákovská A., Kaspárková J., Balcarová Z., Kleinwächter V., Vrána O., Farrell N., and Brabec V. Eur. J. Biochem. 246 (1997) 508
152. Kaspárková J., Nováková O., Vrána O., Farrell N., and Brabec V. Biochemistry 38 (1999) 10997
153. Hindmarsh K., House D.A., and Turnbull M.M. Inorg. Chim. Acta 257 (1997) 11
154. Miller S.E., and House D.A. Inorg. Chim. Acta 161 (1989) 131
155. Hegmans A., Berners-Price S.J., Davies M.S., Thomas D.S., Humphreys A.S., and Farrell N. J. Am. Chem. Soc. 126 (2004) 2166
156. Cox J.W., Berners-Price S.J., Davies M.S., Qu Y., and Farrell N. J. Am. Chem. Soc. 123 (2001) 1316
157. Kasparkova J., Zehnulova J., Farrell N., and Brabec V. J. Biol. Chem. 277 (2002) 48076
158. Qu Y., Scarsdale N.J., Tran M.-C., and Farrell N. J. Biol. Inorg. Chem. 8 (2002) 19
159. McGregor T.D., Bousfield W., Qu Y., and Farrell N. J. Inorg. Biochem. 91 (2002) 212
160. Kasparkova J., Farrell N., and Brabec V. J. Biol. Chem. 275 (2000) 15789
161. Ohndorf U.-M., Whitehead J.P., Raju N.L., and Lippard S.J. Biochemistry 36 (1997) 14807
162. Ohndorf U.-M., Rould M.A., He Q., Pabo C.O., and Lippard S.J. Nature 399 (1999) 708
163. Berners-Price S.J., Davies M.S., Cox J.W., Thomas D.S., and Farrell N. Chem. Eur. J. 9 (2003) 713
164. Kloster M.B.G., Hannis J.C., Muddiman D.C., and Farrell N. Biochemistry 38 (1999) 14731
165. Davies M.S., Berners-Price S.J., Cox J.W., and Farrell N. Chem. Commun. (2003) 122
166. Oehlsen M.E., Qu Y., and Farrell N. Inorg. Chem. 42 (2003) 5498
167. Oehlsen M.E., Hegmans A., Qu Y., and Farrell N. Inorg. Chem. 44 (2005) 3004
168. Oehlsen M.E., Hegmans A., Qu Y., and Farrell N. J. Biol. Inorg. Chem. 10 (2005) 433
169. Appleton T.G., Hall J.R., and Ralph S.F. Inorg. Chem. 24 (1985) 673
170. Clore G.M., and Gronenborn A.M. J. Am. Chem. Soc. 104 (1982) 1369
171. Miller S.K., and Marzilli L.G. Inorg. Chem. 24 (1985) 2421
172. Kline T.P., Marzilli L.G., Live D., and Zon G. J. Am. Chem. Soc. 111 (1989) 7057
173. Bierbach U., Roberts J.D., and Farrell N. Inorg. Chem. 37 (1998) 717
174. Kerrison S.J.S., and Sadler P.J. J. Chem. Soc., Chem. Commun. (1977) 861
175. Ali M.S., Ali Khan S.R., Ojima H., Guzman I.Y., Whitmire K.H., Siddik Z.H., and Khokhar A.R. J. Inorg. Biochem. 99 (2005) 795
176. Jansen B.A.J., Brouwer J., and Reedijk J. J. Inorg. Biochem. 89 (2002) 197
177. Qu Y., and Farrell N. J. Am. Chem. Soc. 113 (1991) 4851
178. Appleton T.G., Berry R.D., Davis C.A., Hall J.R., and Kimlin H.A. Inorg. Chem. 23 (1984) 3514
179. Boreham C.J., Broomhead J.A., and Fairlie D.P. Aus. J. Chem. 34 (1981) 659
180. Prenzler P.D., and McFadyen W.D. J. Inorg. Biochem 68 (1997) 279
181. Guo Z., Hambley T.W., Murdoch P.d.S., Sadler P.J., and Frey U. J. Chem. Soc. Dalton Trans. (1997) 469
182. Barnham K.J., Guo Z., and Sadler P.J. J. Chem. Soc. Dalton Trans. (1996) 2867